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The vision of The Cochrane Collabo-
ration is that healthcare decision-making
be informed by high-quality, timely re-
search evidence. Now, 20 years on from
when it was established, the organization
is making a substantive contribution
globally to realizing this vision. Systematic
reviews prepared and maintained by
members of The Cochrane Collaboration
are published in the Cochrane Database of
Systematic Reviews (CDSR). As one of the
seven databases in The Cochrane Library
(www.thecochranelibrary.com), it includes
all completed Cochrane Reviews and
Protocols outlining the methods of re-
views in progress. Both Protocols and full
versions of the Reviews follow rigorous
methodology and are peer-reviewed.
They differ from other (narrative) types
of literature reviews that are common in
the medical literature (Table S1) but share
features of good quality with many
systematic reviews published elsewhere.
Launched in 1995, the CDSR evolved
from previously existing databases [1].
The first issue included 36 Cochrane
Reviews and 16 Protocols. The CDSR
has grown steadily to more than 5000 full
Reviews and over 2000 Protocols across
all areas of healthcare, most focusing on
the effects of interventions. In parallel,
global access to the CDSR has more than
doubled since 2006 (Figure 1).
Over the past two decades, The Co-
chrane Collaboration has broadened the
international reach of its membership: from
some 77 people from nine countries, who
met for the first Cochrane Colloquium in
1993, to more than 28,000 contributors in
over 100 countries in 2013. This interna-
tional growth did not happen by chance:
The Cochrane Collaboration’s strategy
from the start has been to train people for
evidence synthesis and to build research
capacity, principally through Cochrane
Centres and Branches located in Europe,
the Americas, Asia, Africa, and Australasia.
Cochrane Reviews are prepared and
published in English as many people in the
organisation are from English-speaking
countries and because English dominates
scientific communication. Currently, how-
ever, The Cochrane Collaboration is
examining options for multilingual publi-
cation of Cochrane Reviews and, in
coincidence with its 20thanniversary, has
made strategic decisions to address this
issue. This Essay describes how the organi-
sation is responding to the challenge of
promoting evidence-informed health care
by publishing its high-quality content in
languages other than English.
Translations of Cochrane
Reviews
The Need and Feasibility
Linguistically, the world is very diverse:
the languages spoken by most native
speakers are Mandarin (14%), Spanish
(6%), and English (5%) [2]. Although most
educated health professionals and re-
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searchers can read texts in English, many
others are not able to do so. The
Cochrane Collaboration’s target audience
is broad, including health professionals,
consumers, caregivers, and policy makers.
For many of these groups, the proportion
of people who can benefit from research-
related information limited to English is
actually quite small. In any country in the
world, information about the effectiveness
or harm of an intervention should ideally
be available in the language used by its
population, thus increasing the chances
that this information is consulted. As an
example, consider Africa, the continent
with the greatest disease burden. In
addition to multiple local languages, 115
million people across 31 countries speak
French [3]. Thus, Cochrane Reviews
made available only in English severely
limit their potential to inform decision-
making where evidence about the benefits
and harms of healthcare interventions is
needed urgently [4].
It seems clear that translation is a
crucial strategy to meeting that challenge
and, in fact, The Cochrane Collabora-
tion’s principles include the explicit
commitment to enable wide participation
by reducing barriers to contributing,
encouraging diversity, and promoting
access to its outputs through wide
dissemination to meet the needs of users
worldwide [5]. Fortunately, diverse ini-
tiatives have been promoted within The
Cochrane Collaboration that permit the
organization to be optimistic about the
achievement of those goals. Translations
have the potential to increase the usage
of Cochrane Reviews. La Biblioteca Co-
chrane Plus (www.bibliotecacochrane.com),
the Spanish version of The Cochrane
Library, has pioneered translation and
has become the most comprehensive
project to translate Cochrane content
(Box 1). Since 2003, its usage statistics
have consistently demonstrated that uni-
versal access to content in Spanish across
Spain and Latin America is used by
millions of people every year. French
translations of all abstracts of Cochrane
Reviews published since 2010 and of
content on the consumer-focused Co-
chrane Summaries website (summaries.-
cochrane.org) have shown this effect as
well. The number of visitors to the
French-language version of Cochrane
Summaries per month has almost quin-
tupled, from about 10,000 in September
2012 to 50,000 in May 2013. Over the
same period, France moved from ranking
eighth to second among the countries
with the highest rates of access of
Cochrane Summaries.
Several other initiatives on a smaller
scale than the Spanish and French trans-
lations have focused on the translation of
selected abstracts and plain language
summaries, often with non-professionals
in mind as the primary audience. Such
translations have been prepared or are
planned in such diverse languages as
Simplified and Traditional Chinese, Por-
tuguese, Croatian, German, Japanese,
Russian, Korean, and Indonesian (www.
cochrane.org/editorial-and-publishing-policy-
resource/translation-projects).
Plans and Challenges
A number of challenges have emerged
when translating Cochrane Reviews. The
first is ensuring high quality across all
translations, given the different methods
and resources used for translating. Also, the
meaning of certain terms and concepts may
vary across cultures, even if they share the
same language (Box 2).The second chal-
lenge arises as Cochrane Reviews are
updated periodically, and keeping track of
updates is a huge task. The third, specific to
countries with several official languages, is
the need to translate the same content into
several languages concurrently (Boxes 3
and 4). The fourth is that available
translations have been spread over different
platforms, many of them partially outdated
and difficult to track, in part because The
Cochrane Collaboration has not previously
developed a centrally co-ordinated and
funded strategy. The fifth arises from trying
to decide what content to translate: one
option is to translate plain language
summaries and abstracts of the most recent
and up-to-date reviews. Translating the full
text of all Cochrane Reviews may not be
feasible in some settings, so user demand
must be considered before engaging in
Summary Points
N Cochrane Reviews, systematic reviews prepared by The Cochrane Collaboration,
aim to inform healthcare decision-making anywhere in the world by providing
high-quality timely critical summaries of research evidence.
N All Cochrane Reviews are prepared and published in English, but during its 20th
anniversary year, The Cochrane Collaboration is responding to the challenge to
increase access and global reach through translations into other languages.
N Current projects to translate Cochrane content into Spanish and French are
promising as usage statistics increase with greater provision of translated
content. Enhanced ways to search and access Cochrane Reviews in different
languages will improve the user experience and availability of content.
N New technologies, such as machine translation using learning systems,
translation crowd-sourcing, and the use of a controlled language for the
original English version have the potential to considerably improve possibilities
to translate Cochrane content at large scale and in several languages.
Figure 1. Full-text downloads of Cochrane Reviews, 2006 to 2012.
doi:10.1371/journal.pmed.1001516.g001
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costly and onerous translation activities.
Some initiatives prioritize topics for trans-
lation by an assessment of decision-maker
demand (Box 3). The final challenge is to
address the need for communication be-
tween the different teams translating re-
views, especially those using the same
language. Given the way The Cochrane
Collaboration is set up, it is in the ideal and
natural position to streamline translation
initiatives, ensure efficiency and prevent
duplication of effort.
Different methods have been used for
translation projects (Table 1), with no
formal evaluation of the respective outputs
and efficiency. Until now, conventional
translation by professionals or volunteers
has predominated. However, even if
limited to short texts such as abstracts,
these translation methods represent con-
siderable investment that are difficult to
maintain over time and, due to the related
cost, hard to extend to multiple languages.
In fact, only those projects with permanent
public funding have succeeded to maintain
the necessary continuity.
Sustaining any translation effort de-
pends on the extent to which certain
technologies (such as machine translation)
can support humans in the accurate
translation of content from English into
other languages. Relying exclusively on
human translation is probably too variable
and expensive. However, whether a trans-
lation technology performs well depends
directly on the complexity of the language
and the specificity of the terminology used.
The language used in Cochrane Reviews
is both specialised from a technical point
of view (as it uses specific methodo-
logical terms) and diverse (as reviews are
conducted in various fields of health
care). Therefore, a first line of strategic
development around translations is to
develop a controlled language and then
to use it as much as possible in order to
standardise the text sources that are to be
translated. The quality of machine trans-
lation improves significantly if the prima-
ry text uses terminology in an unambig-
uous and consistent way. A controlled
language is defined as using a restricted
vocabulary, streamlined grammar, and a
defined set of stylistic rules [6]. Using a
controlled English language to simplify
technical texts with a view to improve the
efficiency of future translations would also
increase the readability of the source text
for users who are less proficient in
English [7]. Some problems faced with
partial or full translation of Cochrane
Reviews have been related to ambiguity
of the language in the source documents.
This feature is not surprising if one
considers that the CDSR is compiled of
text written by several thousand different
authors, many of whom are non-native
English speakers.
Conceptually, the approach of moving
to a controlled language is close to one
already developed by the Cochrane Effec-
tive Practice and Organisation of Care
(EPOC) Group, one of the 53 Cochrane
Review Groups, which helps Review
authors formulate clear and consistent
statements about the effect of interventions
[8]. A defined list of qualitative statements
is proposed to express the magnitude of
effect and the quality or certainty of
evidence; for instance, ‘‘The [intervention]
probably slightly improves/reduces [out-
come] for an intervention with a moderate
quality of evidence and a less important
benefit/harm.’’
The Spanish and French translation
projects have to date been working with
computer-aided translation (CAT) soft-
ware such as Deja` Vu. This software has
the capacity to learn and recognise
language patterns, which helps the trans-
lators to be consistent and reduces the
amount and cost of text to be translated
(Table 1). However, using CAT is expen-
sive because it relies heavily on human
input. As a result, it seems more promising
to explore and improve the performance
of automatic translation, assuming that it
would be greatly facilitated if the original
text in English is as standardised as
possible. Based on these criteria, the
Box 1. Biblioteca Cochrane Plus
La Biblioteca Cochrane Plus (www.bibliotecacochrane.com) is the Spanish version
of The Cochrane Library. Designed and promoted by the Iberoamerican Cochrane
Centre in 1998, it has become a reference electronic resource for the
dissemination of Cochrane Reviews in Spanish-speaking countries. Free access
has been funded by the Spanish Ministry of Health with contributions from the
Pan American Health Organisation (via BIREME provision) for Latin American
users. Until 2010 it included the full text of each Cochrane Review translated and
updated when necessary. In the last 3 years and to keep the project sustainable,
only the abstract, plain language summary, and most relevant parts of each
Review are translated with a link to the full English version provided. In August
2013, full or partial content of 5467 Cochrane Reviews was available in Spanish.
The average number of inquiries from users was around 3.5 to 4 million per year
over the past 5 years and in 2012, more than 4.5 million people consulted the
Biblioteca Cochrane Plus. This electronic resource also includes other evidence-
based materials originally published in Spanish. Moreover, the Iberoamerican
Cochrane Centre has also translated other evidence-based content including
podcasts, training materials and guidance documents, such as the Cochrane
Handbook for Systematic Reviews of Interventions, and the Methodological
Expectations of Cochrane Intervention Reviews (MECIR).
Box 2. 19 Years of Small-Scale Translation of Cochrane Review
Abstracts and Summaries in Evidence Update
Since 1994, the Effective Health Care Research Consortium (EHCRC) has been
active in many countries in preparing Cochrane Reviews and disseminating their
findings, often through their own bespoke summaries called Evidence Update
(www.evidence4health.org/evidence.htm). At various times, these summaries
have been translated into Portuguese, Spanish, French, Thai, Russian, and
Chinese. However, translation is usually not straightforward: in one institution in
Thailand, a country with a strong tradition of bilingual medical training, users
preferred the original English language product. In other countries, the accuracy
of the translation was problematic, not because of poor translation, but because
the words mean different things. For instance, work in China on translation in
qualitative research showed that there are often phrases and words without any
English equivalent or with more than one meaning [9]. In a recent pilot translation
project at the Chongqing Medical University in China, 100 abstracts and plain
language summaries of Cochrane Reviews were first translated from English to
Traditional Chinese by a team of experienced translators from Taiwan and then
converted into Simplified Chinese characters. However, machine translation in the
second step resulted in versions that were virtually unusable, and the team had to
go back to the English version and re-translate all of the abstracts. Quality
assurance in the process was essential to obtain correct translations.
Translating Cochrane Reviews
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French Cochrane Centre has partnered
with language experts to train a machine
translation system using large multilingual
text sources and Cochrane Review ab-
stracts already translated into several
languages (Box 5).
The performance of any software used
for translation increases with the amount
of suitable training text that is fed into it. A
body of literature, glossaries of technical
terms, or systematic domain terminologies
already translated in several languages can
be used to improve its performance in a
certain area of content and to reduce the
workload related to post-editing. For
instance, international organisations, such
as the World Health Organization or the
European Medicines Agency, have large
multilingual resources relevant to health
care. Also, the CONSORT Statement and
other reporting guidelines contain relevant
methodological terminology and are avail-
able in several languages (www.equator-
network.org/). The amount and quality of
the material available in different languag-
es varies greatly and therefore limits its
usability to improve machine translation.
Research may help to identify what
minimum size of corpora is required to
achieve the desired level of quality.
Another interesting approach to transla-
tion, taken by Epistemonikos (www.
epistemonikos.org), is based on crowd-
sourcing. The project uses freely available
software to translate medical texts, includ-
ing Cochrane Review abstracts, into Span-
ish (among eight other languages). The
translated texts are further reviewed by
volunteering clinicians or senior students
without formal training in translation, who
receive continuous feedback from more
experienced contributors (Table 1). Tagged
key terms are stored as linked data, which
make them searchable, e.g., in taxonomic
or Patient-Intervention-Comparison-Out-
come (PICO) searches in other products
and software, and useful for future devel-
opments. Regardless of the software used
for translation, validating the text produced
by the machine is always necessary. Again,
a collaborative approach such as that taken
by Epistemonikos can be efficient and
valuable in terms of social contributions,
similar to Wikipedia.
A strategic approach to producing
content in languages other than English
could encompass The Cochrane Collab-
oration’s training materials or derivatives,
and perhaps even its content management
applications. For example, a researcher
could conduct a systematic review in his
or her own language and have it trans-
lated into English at a later stage. Also, a
writing aid tool could be integrated to
facilitate the authoring of reviews in
controlled or simplified English. Such a
tool would automatically propose specific
standardised expressions or paragraphs to
assist review authors in writing in an
unambiguous way, thus simplifying the
translation and improving the readability
for both non-native and native English
speakers.
Providing Access
The best option for providing access to
translated Cochrane Reviews may be to
publish all available translations in any
language, including English, on a common
multilingual platform. The interface
should allow for user-friendly search and
browse in all available languages. The
design should facilitate quick navigation
between the different languages (again,
taking the Wikipedia model). In terms of
search, there is a need to distinguish
between two different approaches for
returning search results by language: the
more simple is a search and browse
function for various languages that only
returns results for one language at a time;
and the more complex (and probably most
challenging to implement) is a multilingual
search engine, which returns results in
multiple languages at the same time.
Another important aspect to take into
account is mobile access via applications
(apps). The free iPad application for The
Cochrane Library launched in 2012 has
proved popular across the globe. Promot-
ing use of small-screen devices and
applications that free up how and when
people can access Cochrane content in
different languages will be an area of
further development. It will be critical
especially in low-resource countries where
smartphones are usually more accessible
than computers with reliable internet
connection.
In 2013, The Cochrane Collaboration
took the first step towards its vision of
making all Cochrane Reviews open access:
all Cochrane Reviews published from 1
February 2013 will be free to view 12
months after publication (green open
Box 3. Cameroon Experience
Cameroon is – apart from Canada – the only other bilingual country with both
French and English as official languages. However, French is the predominant
language. The Centre for Development of Best Practices in Health (CDBPH) in
collaboration with the Effective Health Care Research Consortium (EHCRC) is
working on a 5-year project to enhance the uptake and use of up-to-date health
research evidence primarily from the CDSR. Efforts to reach non-English-speaking
health stakeholders in Cameroon were hampered by language barriers, notably in
building capacity for conducting Cochrane Reviews, reading and applying the
evidence, or communicating it to policy makers. Consequently, significant
resources were diverted to providing translations of Cochrane Review abstracts
and plain language summaries. A list of priority reviews on topics relevant to
Cameroonian stakeholders and EHCRC targets was established. The quality of
these translations was verified by the French Cochrane Centre and Cameroonian
teams. The CDBPH also started producing bilingual evidence assessments –
summaries of Cochrane Reviews adapted to the local context. These translations
have led to a higher uptake of Cochrane products, with more downloads from the
CDBPH website (www.cdbph.org) and demands for other evidence products,
such as Policy Briefs and Rapid Responses.
Box 4. Dissemination in a Multilingual Country – The Experience
in Switzerland
Switzerland has about 8 million inhabitants; most of them speak German, French,
or Italian. English proficiency is widespread among health professionals but many
prefer reading educational material in their own language. The challenge for
Cochrane Switzerland (swiss.cochrane.org) is to serve a multilingual health care
community. The Cochrane Branch collaborates with one medical education
journal in each language region (Revue Me´dicale Suisse, PRAXIS, and Tribuna
Medica Ticinese). New or updated Cochrane Reviews of interest to general or
internal medicine practitioners are continuously selected and summarised. To put
them in context, clinicians are invited to write short clinical scenarios and
questions, which are then answered using the evidence from the Cochrane
Review. In this way, limited resources of the Cochrane Branch can be used
effectively in order to reach multiple audiences.
Translating Cochrane Reviews
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access) or immediately if authors choose to
pay a publication fee (gold open access).
Other routes to promote access to The
Cochrane Library include providing free one-
click access to all people in low- and
middle-income countries included in the
World Health Organization’s Health
InterNetwork Access to Research Initia-
tive (HINARI) (www.thecochranelibrary.
com/view/0/FreeAccess.html). Histori-
cally, public funds have sustained trans-
lation initiatives and, accordingly, access
to the translated content exceeding the
abstract and plain language summaries
has been free to view in the respective
countries. One example is La Biblioteca
Cochrane Plus, which is free to view in
Spain as well as in eligible HINARI
countries in Latin America. All translated
plain language summaries and abstracts
in the CDSR are free to view anywhere.
Over the coming months and years, The
Cochrane Collaboration will be working
with funders and its publisher to explore
how to move to a publishing model that is
based upon open access but also ensures
Table 1. Methods for Translation of Cochrane Reviews and Related Content.
Method Users Details Quality Resource Implications
Professional translation
and editing
Most larger Cochrane
translation projects
Translations are contracted,
with further editing by
content experts.
High Highest cost compared to
the other models, thus
least sustainable
Computer-aided
translation (CAT;
e.g., De´ja` Vu)
Iberoamerican Cochrane
Centre for La Biblioteca
Cochrane Plus
Professional translators and
editors are capable of using
CAT software. Its most recent
versions combine its output
sequentially with machine
translation.
High, especially when the
software’s translation memory
expands continuously.
High cost, although the
price is graded depending
on the number of
repetitions and matches
with content in the
memory. New
technologies and software
can facilitate coordination
and reduce costs (e.g.,
linked data).
Machine translation
(without further
validation)
Not used Use of automated software.
Many free or paid-for online/
desktop solutions exist.
Lowest compared to the other
methods, but depending
crucially on software’s translation
memory and complexity of
original content.
Low cost but currently not
reliable enough.
Machine translation with
human validation
Not used yet, but being
tested by QUARTET M
(Box 5).
Use of automated software
with further editing by
skilled person.
Very good. Open software can
be trained with existing material,
especially if content is written
in a standardised language
(e.g., Simplified English).
Reasonable cost and
sustainable. Expenses
mainly from adapting
software and translated
material used for
‘‘training’’ software, if
amount of translated
content available is
insufficient.
Machine translation with
human validation by
crowd-sourcing
Epistemonikos, a network
created by the Iberoamerican
Chilean Cochrane Node at the
Pontificia University in Santiago
(www.epistemonikos.org).
Crowd-sourcing in a social
network, where everyone can
contribute to translations
as much or little as they like.
Likely to vary, but probably
acceptable, as mostly committed
people would contribute and
correct each other (Wikipedia
principle).
Very low cost (free
software), although some
co-ordination is needed to
implement style guides,
glossaries, and training
activities.
CAT, computer-aided translation; QUARTET M (Qualite´ de l’Aide a` la Re´daction et de la Traduction; Evaluation du Transfert d’information en Me´decine), multidisciplinary
research group including the French Cochrane Centre, the Laboratoire d’Informatique pour la Me´canique et les Sciences de l’Inge´nieur (LIMSI-CNRS, Paris Sud
University), and the Centre de Linguistique Inter-Langues, de Lexicologie, de Linguistique Anglaise et de Corpus (CLILLAC-ARP, Paris Diderot University).
doi:10.1371/journal.pmed.1001516.t001
Box 5. The Potential of Using Simplified English
Using Simplified English is increasingly recognised as an important strategy to
facilitate translation in various fields. For instance, in aircraft manufacturing and
maintenance, it was employed to render the technical documentation easier to
use and thus safer, as well as more efficient. The French Cochrane Centre has
formed a multidisciplinary research group (QUARTET M) with the Laboratoire
d’Informatique pour la Me´canique et les Sciences de l’Inge´nieur (LIMSI-CNRS, Paris
Sud University), one of the country’s largest research groups working on
language technologies, machine translation, and statistical language modelling,
and with the Centre de Linguistique Inter-Langues, de Lexicologie, de
Linguistique Anglaise et de Corpus (CLILLAC-ARP, Paris Diderot University)
specialized in phraseological and terminological analysis, technical writing, and
the development of writing aid tools for Scientific English. The main focus of the
project is to train a machine translation system using large multilingual text
sources and Cochrane Review abstracts already translated into several languages.
First results from tests using a sample of 600 abstracts translated into French to
train the memory of the software have been promising. Rather than focusing on
the technical problems of automatic translation only, QUARTET M has included a
novel approach to investigate whether the adoption of Simplified English and
writing aid tools has the potential to increase translation productivity,
inclusiveness, accessibility, readability, and user experience. Most importantly, it
is assumed that it would increase the feasibility of machine translation with
human validation considerably. Besides, the usage of Simplified English could
improve identification of Cochrane content in Google searches and enhance the
development of derivative products by facilitating automatic extraction of data.
Translating Cochrane Reviews
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its economic sustainability. Including
translations in these discussions as well
as establishing sound permanent alliances
in different geographical regions will be
crucial to developing sustainable transla-
tion projects.
Conclusions
As the world’s largest producer of
systematic reviews, The Cochrane Collab-
oration sets at its 20th anniversary a high
priority on its global reach and relevance
by engaging in the production of content
in as many languages as possible. The
success of previous experience demon-
strates that when texts in local languages
are provided, usage increases substantially.
At the same time, the potential to produce
cost-effective translations of good quality
using new technologies, crowd-sourcing,
or a combination has never been greater.
If this approach is accompanied by efforts
aimed at simplifying and making the use of
English in reviews more consistent, there is
a real prospect that Cochrane Reviews can
become a genuinely international re-
source. As a global network, The Co-
chrane Collaboration has a considerable
technical capability and benefits from two
decades of work experience in diverse
settings and languages. The organization
will need, however, to continue to build
partnerships around complementary ex-
pertise and with funders to ensure that
people can access the information they
need for healthcare decisions in languages
of their choosing.
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